Alexandria — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
Prevail TherapeuticsMar 2018
HealthtechNew York, US
ASA ABELIOVICH(Executive Officer, Director)in
BoardPETER THOMPSON(Director)inMONA ASHIYA(Director)inCARL GORDON(Director)in
Co-investorsEcoR1 CapitalOrbiMedRA Capital
Tiburio TherapeuticsDec 2018
BiotechCambridge, US
James G. McArthur(Executive Officer)Abraham N. Ceesay(Executive Officer)Christoph M. Adams(Executive Officer, Director)
BoardMette Kirstine Agger(Director)David Mott(Director)Sandip Agarwala(Director)
Co-investorsLongitude CapitalLundbeckfonden VenturesNew Enterprise Associates (NEA)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.